title: Differential roles of JNK in ConA/GalN and ConA-induced liver injury in mice.
abstract: Tumor necrosis factor-alpha-mediated liver injury can be induced by several different means; however, the signaling events and mechanisms of cell death are likely different. We investigated the mechanism of both apoptotic and necrotic hepatocyte cell death as well as the role of c-Jun NH2-terminal kinase (JNK) in the ConA and ConA/D-galactosamine (GalN) models of murine liver injury. ConA alone induced primarily necrotic cell death with no caspase activation, whereas ConA/GalN induced apoptosis in addition to necrotic cell death. The bi-modal death pattern in the ConA/GalN model was confirmed by the use of transgenic mice expressing a dominant-negative form of Fas-associated death domain in which the mice were resistant to apoptotic but not necrotic cell death. JNK1 and, more significantly, JNK2 participated in the induction of hepatocyte apoptosis in response to ConA/GalN. Deletion of JNK led to the stabilization of FLIP L, reduced caspase-8 activation, decreased Bid cleavage, and inhibition of the mitochondrial apoptosis pathway. In contrast, JNK did not participate in necrotic death induced by ConA either alone or in combination with GalN. As such, JNK-deficient mice remained susceptible to necrotic liver injury in both model systems. Thus, ConA and ConA/GalN mouse models induce liver injury with different mechanisms of cell death, and JNK contributes to apoptotic but not necrotic cell death. These findings further elucidate the specific pathways involved in tumor necrosis factor-alpha-mediated liver injury.
authors.affiliation: Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
authors.forename: Hong-Min
authors.initials: HM
authors.lastname: Ni
authors.forename: Xiaoyun
authors.initials: X
authors.lastname: Chen
authors.forename: Wen-Xing
authors.initials: WX
authors.lastname: Ding
authors.forename: Marcus
authors.initials: M
authors.lastname: Schuchmann
authors.forename: Xiao-Ming
authors.initials: XM
authors.lastname: Yin
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D051023:BH3 Interacting Domain Death Agonist Protein / Q000378:metabolism; D053181:Caspase 8 / Q000378:metabolism; D056486:Chemical and Drug Induced Liver Injury; D003208:Concanavalin A; D004195:Disease Models, Animal; D004789:Enzyme Activation / Q000187:drug effects; D053200:Fas-Associated Death Domain Protein / Q000378:metabolism; D005688:Galactosamine; D017353:Gene Deletion; D048031:JNK Mitogen-Activated Protein Kinases / Q000378:metabolism*; D008107:Liver Diseases / Q000201:enzymology* / Q000473:pathology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008930:Mitochondria, Liver / Q000187:drug effects / Q000201:enzymology / Q000473:pathology; D050505:Mutant Proteins / Q000378:metabolism; D009336:Necrosis; D010766:Phosphorylation / Q000187:drug effects
chemical_list: D051023:BH3 Interacting Domain Death Agonist Protein; D053200:Fas-Associated Death Domain Protein; D050505:Mutant Proteins; D003208:Concanavalin A; D005688:Galactosamine; D048031:JNK Mitogen-Activated Protein Kinases; D053181:Caspase 8
references.citation: J Clin Invest. 1998 May 1;101(9):1960-9
references.pmid: 9576761
references.citation: Nature. 2001 Nov 15;414(6861):313-7
references.pmid: 11713531
references.citation: Nature. 1999 Aug 26;400(6747):886-91
references.pmid: 10476969
references.citation: Hepatology. 1999 Nov;30(5):1241-51
references.pmid: 10534346
references.citation: J Clin Invest. 2004 Jan;113(1):58-64
references.pmid: 14702109
references.citation: EMBO J. 2004 Apr 21;23(8):1889-99
references.pmid: 15071501
references.citation: Mol Pharmacol. 2006 Sep;70(3):1099-108
references.pmid: 16798936
references.citation: Cell. 2006 Feb 10;124(3):601-13
references.pmid: 16469705
references.citation: EMBO Rep. 2006 Oct;7(10):988-94
references.pmid: 17016456
references.citation: J Clin Invest. 2002 Nov;110(10):1503-13
references.pmid: 12438448
references.citation: Biochim Biophys Acta. 1998 Aug 10;1366(1-2):177-96
references.pmid: 9714796
references.citation: Am J Physiol Gastrointest Liver Physiol. 2006 Apr;290(4):G583-9
references.pmid: 16537970
references.citation: Cell Death Differ. 2003 Jan;10(1):45-65
references.pmid: 12655295
references.citation: Mol Cell Biol. 2004 Dec;24(24):10844-56
references.pmid: 15572687
references.citation: J Biol Chem. 2001 Jul 20;276(29):27432-40
references.pmid: 11369777
references.citation: Science. 2000 May 5;288(5467):870-4
references.pmid: 10797012
references.citation: J Cell Mol Med. 2004 Oct-Dec;8(4):445-54
references.pmid: 15601573
references.citation: Hepatology. 2003 Jan;37(1):129-35
references.pmid: 12500197
references.citation: Transplantation. 2008 May 27;85(10):1500-4
references.pmid: 18497693
references.citation: Cell. 2000 Jul 7;102(1):33-42
references.pmid: 10929711
references.citation: Cell. 2004 Nov 12;119(4):529-42
references.pmid: 15537542
references.citation: Oncogene. 2003 Dec 8;22(56):8961-82
references.pmid: 14663476
references.citation: Gastroenterology. 1998 May;114(5):1035-45
references.pmid: 9558294
references.citation: Nature. 2001 Nov 15;414(6861):308-13
references.pmid: 11713530
references.citation: Gastroenterology. 2006 Jul;131(1):165-78
references.pmid: 16831600
references.citation: Genes Dev. 1996 Nov 15;10(22):2859-69
references.pmid: 8918887
references.citation: J Biol Chem. 2004 Mar 12;279(11):10822-8
references.pmid: 14701813
references.citation: FASEB J. 2004 Apr;18(6):720-2
references.pmid: 14766793
references.citation: J Biol Chem. 2006 Jun 2;281(22):15258-67
references.pmid: 16571730
references.citation: Hepatology. 1995 Jan;21(1):190-8
references.pmid: 7806154
references.citation: Hepatology. 2004 Aug;40(2):403-13
references.pmid: 15368445
references.citation: Cell. 2005 Mar 11;120(5):649-61
references.pmid: 15766528
references.citation: Nature. 1997 Jul 10;388(6638):190-5
references.pmid: 9217161
references.citation: Science. 2004 Sep 3;305(5689):1471-4
references.pmid: 15353805
references.citation: Immunity. 2003 Nov;19(5):725-37
references.pmid: 14614859
references.citation: Hepatology. 2002 Apr;35(4):772-8
references.pmid: 11915022
references.citation: Mol Cell Biol. 2007 Jan;27(2):541-53
references.pmid: 17101783
references.citation: J Clin Invest. 2003 Apr;111(7):973-80
references.pmid: 12671046
references.citation: Mol Cell. 2004 Sep 10;15(5):713-25
references.pmid: 15350216
references.citation: Cell. 2000 Oct 13;103(2):239-52
references.pmid: 11057897
references.citation: J Immunol. 2001 Jul 1;167(1):514-23
references.pmid: 11418690